VQW-765 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 4mo
ESTIMATED |
READOUT
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment
Phase 3 · Social Anxiety Disorder (SAD) |
VNDA Vanda Pharmaceuticals Inc. | VQW-765 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|